Document Detail


Cardiovascular benefits of antihypertensive therapy postacute myocardial infarction. Therapeutic considerations.
MedLine Citation:
PMID:  7512482     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Patients who survive a myocardial infarction are at high risk of future recurrent infarction, sudden death and other vascular events. While it is possible to predict many risks, it is not possible to predict reinfarction. Since reinfarction carries a poor prognosis we should attempt to reduce this risk in all patients who survive an acute myocardial infarction. This paper reviews the wide range of lifestyle modifications and pharmacological interventions aimed at improving the long term prognosis of patients who have suffered an acute myocardial infarction.
Authors:
P Sleight
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Drugs     Volume:  46 Suppl 2     ISSN:  0012-6667     ISO Abbreviation:  Drugs     Publication Date:  1993  
Date Detail:
Created Date:  1994-05-19     Completed Date:  1994-05-19     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  7600076     Medline TA:  Drugs     Country:  NEW ZEALAND    
Other Details:
Languages:  eng     Pagination:  48-53     Citation Subset:  IM    
Affiliation:
John Radcliffe Hospital, Headington, Oxford, England.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Antihypertensive Agents / therapeutic use*
Humans
Myocardial Infarction / complications,  physiopathology,  prevention & control*
Recurrence
Risk
Chemical
Reg. No./Substance:
0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmacological aspects of calcium antagonism. Short term and long term benefits.
Next Document:  Postinfarct treatment with verapamil. Effect of verapamil in patients with hypertension.